Table 6.
Outcome Used | R Sq. | Predictors in the Model | Coefficient | 95% Confidence Interval |
p |
---|---|---|---|---|---|
Resistance to Meropenem | 0.627 | Consumption of Imipenem 1 month before | 0.0243 | [−0.0043, 0.0529] | 0.078 |
Consumption of Meropenem 1 month before | −0.0016 | [−0.0057, 0.0025] | 0.341 | ||
Resistance to Meropenem | 0.753 | Consumption of Imipenem 2 months before | 0.0075 | [0.0011, 0.0130] | 0.032 * |
Consumption of Meropenem 2 months before | −0.0042 | [−0.0077, 0.0081] | 0.027 | ||
Resistance to Ciprofloxacin | 0.753 | Consumption of Imipenem 2 months before | 0.0010 | [0.0007, 0.0014] | <0.001 * |
Consumption of Meropenem 2 months before | −0.0002 | [−0.0001, 0.0010] | 0.094 | ||
Consumption of Ciprofloxacin 2 months before | 0.0004 | [0.0001, 0.0007] | 0.0047 * | ||
Resistance to Ciprofloxacin | 0.537 | Consumption of Imipenem 3 months before | 0.0064 | [0.0004, 0.0009] | <0.001 |
Consumption of Meropenem 3 months before | 0.0001 | [−0.0002, 0.0004] | 0.571 | ||
Consumption of Ciprofloxacin 3 months before | −0.0001 | [−0.0004, 0.0001] | 0.330 |
* p < 0.05.